Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Unbelievable! Stock of herbal medicine company, with zero revenue, rallies whopping 46,000% - what’s causing this surprising rise?

Needham & Company LLC reaffirmed their buy rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a research report sent to investors on Tuesday,Benzinga reports. The firm ...

Two prominent gene-editing startups, Chroma Medicine and Nvelop Therapeutics, said Wednesday they will merge, forming a new company called nChroma Bio. The merger will combine molecular machines ...

Gufic Biosciences Q1 Results Live : Gufic Biosciences declared their Q1 results on 14 Aug, 2024. The company reported a revenue increase of 4% year-over-year (YoY) and a profit increase of 1.13% YoY.

Blueprint Medicines' treatment for a rare blood disorder earned it a spot on Fast Company's list of most innovative medicines and therapeutics companies.

Insilico Medicine (“Insilico”), a clinical stage artificial intelligence (AI)-driven drug discovery company, has been named the top biotech company in Fast Company’s 2024 World’s Most ...

Gufic Biosciences gains on Aussie, Brazilian nod to pain-killer drug "The medicine will be used for short-term treatment of acute pain and post-operative pain in adult patients,” the company ...

Gufic Biosciences' shares rose 2.31% after receiving approvals from TGA and ANVISA for Parecoxib Sodium, a selective COX-2 inhibitor for short-term pain management. Parecoxib, a prodrug of ...